Photodermatosis associated with eculizumab (Soliris): a novel monoclonal antibody directed against the complement protein C5

Am J Hematol. 2010 May;85(5):392-3. doi: 10.1002/ajh.21672.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Complement C5 / antagonists & inhibitors*
  • Female
  • Hemoglobinuria, Paroxysmal / drug therapy*
  • Humans
  • Photosensitivity Disorders / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Complement C5
  • eculizumab